Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Hanying Bao, MD,PhD
CONTACT
Xiaoming Zhang, PhD
CONTACT
Lead
Shanghai YingLi Pharmaceutical Co. Ltd.
The study will be conducted in China to provide safety and efficacy data from this region. A Safety Run-in will be conducted to confirm the safety of the recommended Phase 2 dose (RP2D), 80 mg once daily, in a Asian population. PK samplings at Cycle 1, Day 1 will be taken.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted